
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-06 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sale | 251 | $5.05 | $1K | 96.1K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Thompson Travis Alvin | Chief Financial Officer | Sale | 102 | $5.05 | $515.10 | 65.4K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Perry Jennifer Scott | Chief Operating Officer | Sale | 370 | $5.04 | $2K | 92.5K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Lee Kevin | Director & CHIEF EXECUTIVE OFFICER | Sale | 1,716 | $5.05 | $9K | 611.3K | View ↗ | |
| 2026-04-06 | 2026-04-06 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sale | 525 | $5.05 | $3K | 159.6K | View ↗ |
No annual data found.
Corbus Pharmaceuticals: I'd Preach Caution After Selloff On Latest Data Drop
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading